US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

5.66

+0.03000.53%

Post-market: 5.660.00000.00%19:30 EDT

Volume:217.71K

Turnover:1.23M

Market Cap:213.59M

PE:-5.44

High:5.80

Open:5.67

Low:5.60

Close:5.63

52wk High:7.19

52wk Low:1.00

Shares:37.74M

Float Shares:19.75M

Volume Ratio:1.01

T/O Rate:1.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0401

EPS(LYR):-1.1641

ROE:-50.12%

ROA:-30.80%

PB:2.81

PE(LYR):-4.86

Loading ...

Overview Company News Filings

AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

AN2 Therapeutics Q1 FY26 net loss narrows 5.83% to $10 million

AN2 Therapeutics Q1 EPS USD -0.29

THOMSON REUTERS

Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights

AN2 Therapeutics CEO joins Stifel Virtual Targeted Oncology Forum fireside chat

AN2 Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview

AN2 Therapeutics announces annual shareholder meeting

BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies

AN2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies Llc Dated April 9, 2026 - SEC Filing

THOMSON REUTERS

AN2 Therapeutics Inc - May Offer and Sell Common Stock up to $80 Mln Through Jefferies - SEC Filing

THOMSON REUTERS

BRIEF-An2 Therapeutics Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing

AN2 Therapeutics Files $300 Million Mixed Shelf

MT Newswires Live

AN2 Therapeutics files $300M mixed securities shelf

AN2 Therapeutics Inc - May Offer up to $80 Mln of Common Stock Under Agreement With Jefferies Llc - SEC Filing

THOMSON REUTERS

AN2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies for up to $80 Mln Common Stock - SEC Filing

THOMSON REUTERS

AN2 Therapeutics Inc - Terminates TD Cowen Sales Agreement Effective April 9, 2026 - SEC Filing

THOMSON REUTERS

AN2 Therapeutics enters $80 million at-the-market equity sales agreement with Jefferies

AN2 Therapeutics starts Phase 2 epetraborole trial in M. abscessus lung disease

AN2 Therapeutics Inc - Expects Three Phase 2 Studies Active in 2026

THOMSON REUTERS

AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium Abscessus Complex Lung Disease

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ANTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":5.66,"timestamp":1787688000000,"preClose":5.63,"halted":0,"volume":217706,"hourTrading":{"tag":"盘后","latestPrice":5.66,"preClose":5.66,"latestTime":"19:30 EDT","volume":470,"amount":2660.2,"timestamp":1787700600856,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005328596802841963,"floatShares":19748300,"shares":37736200,"eps":-1.040051,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"08-25 16:00:00 EDT","open":5.67,"high":5.8,"low":5.6,"amount":1234881.0515402,"amplitude":0.035524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.040051,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":5.63,"postHourTrading":{"tag":"盘后","latestPrice":5.66,"preClose":5.66,"latestTime":"19:30 EDT","volume":470,"amount":2660.2,"timestamp":1787700600856,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.013533,"impliedVol":1.6866,"impliedVolPercentile":0.4643},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":19748300,"roa":"-30.80%","roe":"-50.12%","lyrEps":-1.164094,"volumeRatio":1.013533,"shares":37736200,"dividePrice":0,"high":5.8,"amplitude":0.035524,"preClose":5.63,"low":5.6,"week52Low":1,"pbRate":"2.81","week52High":7.19,"institutionHeld":0,"latestPrice":5.66,"eps":-1.040051,"divideRate":0,"volume":217706,"delay":0,"ttmEps":-1.040051,"open":5.67,"prevYearClose":1.14,"prevWeekClose":5.81,"prevMonthClose":5.35,"prevQuarterClose":4.84,"fiveDayClose":5.97,"twentyDayClose":4.7,"sixtyDayClose":4.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"ANTX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2026-05-11","symbol":"ANTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-03-17","symbol":"ANTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.24,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2025-11-12","symbol":"ANTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-08-12","symbol":"ANTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":2,"updateTime":1784520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2026-08-24","current":-5.442041,"percent":0.259361,"low":-16.371108,"twenty":-7.532376,"median":-2.992434,"eighty":-0.751848,"high":-0.452319,"avg":-3.971215,"sd":3.645097,"marketCap":219247536},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.899037,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":59359789},{"date":"2024-06-07","current":-0.917108,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":60552951},{"date":"2024-06-14","current":-0.980356,"twenty":-9.610032,"median":-5.995886,"eighty":-2.875774,"marketCap":64729016},{"date":"2024-06-21","current":-0.95325,"twenty":-9.596988,"median":-5.970211,"eighty":-2.763626,"marketCap":62939274},{"date":"2024-06-28","current":-0.971321,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":64132436},{"date":"2024-07-05","current":-1.188174,"twenty":-9.555391,"median":-5.857071,"eighty":-2.458418,"marketCap":78450375},{"date":"2024-07-12","current":-1.165585,"twenty":-9.514113,"median":-5.824371,"eighty":-2.36598,"marketCap":76958923},{"date":"2024-07-19","current":-1.260458,"twenty":-9.453014,"median":-5.802931,"eighty":-2.238133,"marketCap":83223021},{"date":"2024-07-26","current":-1.210763,"twenty":-9.447843,"median":-5.737331,"eighty":-2.128663,"marketCap":79941827},{"date":"2024-08-02","current":-1.165585,"twenty":-9.447142,"median":-5.721772,"eighty":-1.927742,"marketCap":76958923},{"date":"2024-08-09","current":-0.46533,"twenty":-9.442138,"median":-5.694989,"eighty":-1.744863,"marketCap":30723911},{"date":"2024-08-16","current":-0.452319,"twenty":-9.420585,"median":-5.683771,"eighty":-1.649644,"marketCap":29245582},{"date":"2024-08-23","current":-0.507705,"twenty":-9.368585,"median":-5.668525,"eighty":-1.569679,"marketCap":32826674},{"date":"2024-08-30","current":-0.521551,"twenty":-9.363601,"median":-5.629593,"eighty":-1.541673,"marketCap":33721947},{"date":"2024-09-06","current":-0.470781,"twenty":-9.359614,"median":-5.566854,"eighty":-1.505114,"marketCap":30439279},{"date":"2024-09-13","current":-0.480012,"twenty":-9.321551,"median":-5.545658,"eighty":-1.493229,"marketCap":31036128},{"date":"2024-09-20","current":-0.484627,"twenty":-9.274889,"median":-5.510762,"eighty":-1.470227,"marketCap":31334552},{"date":"2024-09-27","current":-0.489243,"twenty":-9.269905,"median":-5.493865,"eighty":-1.445308,"marketCap":31632976},{"date":"2024-10-04","current":-0.493858,"twenty":-9.267426,"median":-5.480973,"eighty":-1.398102,"marketCap":31931401},{"date":"2024-10-11","current":-0.484627,"twenty":-9.213301,"median":-5.440937,"eighty":-1.379706,"marketCap":31334552},{"date":"2024-10-18","current":-0.484627,"twenty":-9.159176,"median":-5.400004,"eighty":-1.260458,"marketCap":31334552},{"date":"2024-10-25","current":-0.493858,"twenty":-9.159176,"median":-5.292741,"eighty":-1.224316,"marketCap":31931401},{"date":"2024-11-01","current":-0.498474,"twenty":-9.104599,"median":-5.27157,"eighty":-1.192692,"marketCap":32229825},{"date":"2024-11-08","current":-0.507705,"twenty":-9.056939,"median":-5.260984,"eighty":-1.175061,"marketCap":32826674},{"date":"2024-11-15","current":-0.492263,"twenty":-9.008828,"median":-5.223935,"eighty":-1.165585,"marketCap":29878890},{"date":"2024-11-22","current":-0.659632,"twenty":-8.984772,"median":-5.186886,"eighty":-1.152032,"marketCap":40037712},{"date":"2024-11-29","current":-0.822079,"twenty":-8.833504,"median":-5.165715,"eighty":-1.14661,"marketCap":49897746},{"date":"2024-12-06","current":-0.708859,"twenty":-8.764395,"median":-5.131312,"eighty":-1.135958,"marketCap":43025601},{"date":"2024-12-13","current":-0.703936,"twenty":-8.75631,"median":-5.107495,"eighty":-1.128429,"marketCap":42726812},{"date":"2024-12-20","current":-0.620251,"twenty":-8.752791,"median":-5.06243,"eighty":-1.10594,"marketCap":37647401},{"date":"2024-12-27","current":-0.708859,"twenty":-8.7388,"median":-5.051921,"eighty":-1.093587,"marketCap":43025601},{"date":"2025-01-03","current":-0.699014,"twenty":-8.706848,"median":-5.044823,"eighty":-1.083887,"marketCap":42428023},{"date":"2025-01-10","current":-0.615329,"twenty":-8.669427,"median":-5.041335,"eighty":-1.044599,"marketCap":37348612},{"date":"2025-01-17","current":-0.625174,"twenty":-8.655656,"median":-5.006933,"eighty":-1.011077,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.642528,"median":-4.99154,"eighty":-0.978098,"marketCap":37348612},{"date":"2025-01-31","current":-0.56118,"twenty":-8.620649,"median":-4.940774,"eighty":-0.957768,"marketCap":34061934},{"date":"2025-02-07","current":-0.531644,"twenty":-8.592106,"median":-4.895785,"eighty":-0.948732,"marketCap":32269201},{"date":"2025-02-14","current":-0.551335,"twenty":-8.592106,"median":-4.864028,"eighty":-0.935179,"marketCap":33464356},{"date":"2025-02-21","current":-0.556257,"twenty":-8.573312,"median":-4.805808,"eighty":-0.928854,"marketCap":33763145},{"date":"2025-02-28","current":-0.56118,"twenty":-8.566482,"median":-4.763467,"eighty":-0.907168,"marketCap":34061934},{"date":"2025-03-07","current":-0.644865,"twenty":-8.539495,"median":-4.726229,"eighty":-0.899037,"marketCap":39141345},{"date":"2025-03-14","current":-0.689168,"twenty":-8.528704,"median":-4.684075,"eighty":-0.782698,"marketCap":41830446},{"date":"2025-03-21","current":-0.718704,"twenty":-8.510156,"median":-4.66401,"eighty":-0.732487,"marketCap":43623179},{"date":"2025-03-28","current":-0.815207,"twenty":-8.48965,"median":-4.562154,"eighty":-0.73741,"marketCap":41837220},{"date":"2025-04-04","current":-0.744829,"twenty":-8.484244,"median":-4.520001,"eighty":-0.742333,"marketCap":38225374},{"date":"2025-04-11","current":-0.750694,"twenty":-8.45484,"median":-4.377097,"eighty":-0.733398,"marketCap":38526361},{"date":"2025-04-17","current":-0.738964,"twenty":-8.433268,"median":-4.263696,"eighty":-0.736426,"marketCap":37924387},{"date":"2025-04-25","current":-0.7331,"twenty":-8.412415,"median":-4.240009,"eighty":-0.733323,"marketCap":37623400},{"date":"2025-05-02","current":-0.715505,"twenty":-8.383057,"median":-4.202436,"eighty":-0.728023,"marketCap":36720438},{"date":"2025-05-09","current":-0.703776,"twenty":-8.368106,"median":-4.076567,"eighty":-0.727235,"marketCap":36118464},{"date":"2025-05-16","current":-0.803022,"twenty":-8.352142,"median":-4.007874,"eighty":-0.727235,"marketCap":36419451},{"date":"2025-05-23","current":-0.789749,"twenty":-8.341681,"median":-3.858652,"eighty":-0.727235,"marketCap":35817476},{"date":"2025-05-30","current":-0.805076,"twenty":-8.337305,"median":-3.749538,"eighty":-0.727235,"marketCap":36512621},{"date":"2025-06-06","current":-0.738541,"twenty":-8.328553,"median":-3.531792,"eighty":-0.727235,"marketCap":33495049},{"date":"2025-06-13","current":-0.751848,"twenty":-8.312143,"median":-3.453864,"eighty":-0.727235,"marketCap":34098563},{"date":"2025-06-20","current":-0.731887,"twenty":-8.285296,"median":-3.37993,"eighty":-0.727235,"marketCap":33193292},{"date":"2025-06-27","current":-0.71858,"twenty":-8.255078,"median":-3.34002,"eighty":-0.72001,"marketCap":32589777},{"date":"2025-07-03","current":-0.69862,"twenty":-8.248692,"median":-3.308058,"eighty":-0.71858,"marketCap":31684506},{"date":"2025-07-11","current":-0.711927,"twenty":-8.237752,"median":-3.300068,"eighty":-0.715505,"marketCap":32288020},{"date":"2025-07-18","current":-0.725234,"twenty":-8.232282,"median":-3.276096,"eighty":-0.715505,"marketCap":32891534},{"date":"2025-07-25","current":-0.731887,"twenty":-8.226812,"median":-3.270104,"eighty":-0.715505,"marketCap":33193292},{"date":"2025-08-01","current":-0.705273,"twenty":-8.204932,"median":-3.244134,"eighty":-0.713781,"marketCap":31986263},{"date":"2025-08-08","current":-0.71858,"twenty":-8.204932,"median":-3.210175,"eighty":-0.711927,"marketCap":32589777},{"date":"2025-08-15","current":-0.771244,"twenty":-8.199462,"median":-3.188201,"eighty":-0.711927,"marketCap":28829104},{"date":"2025-08-22","current":-0.811451,"twenty":-8.188416,"median":-3.162232,"eighty":-0.711927,"marketCap":30332043},{"date":"2025-08-29","current":-0.804141,"twenty":-8.18787,"median":-3.120282,"eighty":-0.713781,"marketCap":30058781},{"date":"2025-09-05","current":-0.921107,"twenty":-8.185512,"median":-3.096311,"eighty":-0.714959,"marketCap":34430967},{"date":"2025-09-12","current":-0.928417,"twenty":-8.183731,"median":-3.036031,"eighty":-0.715455,"marketCap":34704229},{"date":"2025-09-19","current":-0.943038,"twenty":-8.171471,"median":-3.008415,"eighty":-0.715505,"marketCap":35250752},{"date":"2025-09-26","current":-0.906486,"twenty":-8.162634,"median":-2.968463,"eighty":-0.715505,"marketCap":33884444},{"date":"2025-10-03","current":-0.935727,"twenty":-8.156796,"median":-2.88656,"eighty":-0.717965,"marketCap":34977491},{"date":"2025-10-10","current":-0.906486,"twenty":-8.151327,"median":-2.842613,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-10-17","current":-0.862624,"twenty":-8.145857,"median":-2.741598,"eighty":-0.71858,"marketCap":32244874},{"date":"2025-10-24","current":-0.855313,"twenty":-8.140387,"median":-2.608584,"eighty":-0.71858,"marketCap":31971613},{"date":"2025-10-31","current":-0.906486,"twenty":-8.138721,"median":-2.541748,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-11-07","current":-0.818761,"twenty":-8.134774,"median":-2.431944,"eighty":-0.71858,"marketCap":30605304},{"date":"2025-11-14","current":-0.826072,"twenty":-8.105379,"median":-2.385158,"eighty":-0.71858,"marketCap":30878566},{"date":"2025-11-21","current":-0.870776,"twenty":-8.0895,"median":-2.290271,"eighty":-0.71858,"marketCap":29594185},{"date":"2025-11-28","current":-0.878839,"twenty":-8.087308,"median":-2.239332,"eighty":-0.718654,"marketCap":29868206},{"date":"2025-12-05","current":-0.858682,"twenty":-8.080228,"median":-2.177405,"eighty":-0.718704,"marketCap":29183155},{"date":"2025-12-12","current":-0.959466,"twenty":-8.07122,"median":-2.079522,"eighty":-0.718704,"marketCap":32608408},{"date":"2025-12-19","current":-0.919152,"twenty":-8.068254,"median":-1.94369,"eighty":-0.722622,"marketCap":31238307},{"date":"2025-12-26","current":-0.919152,"twenty":-8.065995,"median":-1.918771,"eighty":-0.725234,"marketCap":31238307},{"date":"2026-01-02","current":-0.919152,"twenty":-8.061619,"median":-1.814111,"eighty":-0.725634,"marketCap":31238307},{"date":"2026-01-09","current":-1.064281,"twenty":-8.056565,"median":-1.659612,"eighty":-0.727235,"marketCap":36170671},{"date":"2026-01-16","current":-1.007842,"twenty":-8.046873,"median":-1.649644,"eighty":-0.727235,"marketCap":34252530},{"date":"2026-01-23","current":-0.975591,"twenty":-8.018954,"median":-1.599806,"eighty":-0.727235,"marketCap":33156449},{"date":"2026-01-30","current":-0.911089,"twenty":-8.018954,"median":-1.561041,"eighty":-0.727235,"marketCap":30964287},{"date":"2026-02-06","current":-0.85465,"twenty":-8.018336,"median":-1.548364,"eighty":-0.727235,"marketCap":29046145},{"date":"2026-02-13","current":-0.846588,"twenty":-8.008014,"median":-1.522557,"eighty":-0.728549,"marketCap":28772125},{"date":"2026-02-20","current":-0.878839,"twenty":-7.997233,"median":-1.50013,"eighty":-0.731219,"marketCap":29868206},{"date":"2026-02-27","current":-0.85465,"twenty":-7.965935,"median":-1.493229,"eighty":-0.731887,"marketCap":29046145},{"date":"2026-03-06","current":-1.378728,"twenty":-7.954408,"median":-1.485178,"eighty":-0.731887,"marketCap":46857461},{"date":"2026-03-13","current":-4.38613,"twenty":-7.953314,"median":-1.493229,"eighty":-0.731887,"marketCap":149067010},{"date":"2026-03-20","current":-3.046054,"twenty":-7.948938,"median":-1.50013,"eighty":-0.731887,"marketCap":107141913},{"date":"2026-03-27","current":-3.688739,"twenty":-7.933429,"median":-1.530033,"eighty":-0.731887,"marketCap":129747713},{"date":"2026-04-02","current":-3.525249,"twenty":-7.927508,"median":-1.548364,"eighty":-0.731887,"marketCap":123997122},{"date":"2026-04-10","current":-3.116525,"twenty":-7.925964,"median":-1.561041,"eighty":-0.732615,"marketCap":109620644},{"date":"2026-04-17","current":-3.212452,"twenty":-7.9194,"median":-1.599806,"eighty":-0.7331,"marketCap":112994780},{"date":"2026-04-24","current":-4.379966,"twenty":-7.908405,"median":-1.649644,"eighty":-0.7331,"marketCap":154060932},{"date":"2026-05-01","current":-4.656273,"twenty":-7.894202,"median":-1.659612,"eighty":-0.733323,"marketCap":163779729},{"date":"2026-05-08","current":-4.70744,"twenty":-7.877253,"median":-1.829062,"eighty":-0.736426,"marketCap":165579507},{"date":"2026-05-15","current":-4.833714,"twenty":-7.86479,"median":-1.923755,"eighty":-0.738483,"marketCap":167019328},{"date":"2026-05-22","current":-5.094151,"twenty":-7.847513,"median":-2.027584,"eighty":-0.738541,"marketCap":176018215},{"date":"2026-05-29","current":-4.646199,"twenty":-7.819433,"median":-2.133458,"eighty":-0.738541,"marketCap":160540130},{"date":"2026-06-05","current":-4.344092,"twenty":-7.78668,"median":-2.225348,"eighty":-0.73871,"marketCap":150101422},{"date":"2026-06-12","current":-4.635782,"twenty":-7.780329,"median":-2.261305,"eighty":-0.738964,"marketCap":160180175},{"date":"2026-06-18","current":-5.104569,"twenty":-7.77773,"median":-2.29857,"eighty":-0.739835,"marketCap":176378170},{"date":"2026-06-26","current":-5.357655,"twenty":-7.751023,"median":-2.385158,"eighty":-0.743317,"marketCap":185123067},{"date":"2026-07-02","current":-4.899023,"twenty":-7.685769,"median":-2.421115,"eighty":-0.743317,"marketCap":169275956},{"date":"2026-07-10","current":-4.826059,"twenty":-7.621547,"median":-2.531372,"eighty":-0.744829,"marketCap":166754825},{"date":"2026-07-17","current":-4.867753,"twenty":-7.619647,"median":-2.560948,"eighty":-0.744829,"marketCap":168195471},{"date":"2026-07-24","current":-5.128339,"twenty":-7.614177,"median":-2.722625,"eighty":-0.745194,"marketCap":177199512},{"date":"2026-07-31","current":-5.555701,"twenty":-7.577731,"median":-2.806656,"eighty":-0.749594,"marketCap":191966138},{"date":"2026-08-07","current":-6.33746,"twenty":-7.564385,"median":-2.880568,"eighty":-0.750694,"marketCap":218978258},{"date":"2026-08-14","current":-6.220716,"twenty":-7.555871,"median":-2.938499,"eighty":-0.751617,"marketCap":225662697},{"date":"2026-08-21","current":-6.023068,"twenty":-7.536702,"median":-2.976453,"eighty":-0.751848,"marketCap":218492812},{"date":"2026-08-24","current":-6.043873,"twenty":-7.532376,"median":-2.992434,"eighty":-0.751848,"marketCap":219247536}],"updateTime":1787710323818},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634258103","title":"AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258103?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:01","pubTimestamp":1778533295,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryAN2 Therapeutics Inc ANTX.OQ reported a quarterly adjusted loss of 29 cents per share for the quarter ended March ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232594","title":"AN2 Therapeutics Q1 FY26 net loss narrows 5.83% to $10 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232594?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:02","pubTimestamp":1778529746,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics posted a Q1 net loss of USD 10 million, narrowing from USD 10.6 million a year earlier; loss per share improved to USD 0.29 from USD 0.35.R&D spending fell to USD 6.7 million from USD 7.7 million, while G&A was flat at USD 3.8 million.Interest income slipped to USD 0.5 million from USD 0.9 million on lower average cash balances and lower interest rates.Cash, cash equivalents and investments totaled USD 85.3 million at March 31, following a USD 40 million private placement; cash runway projected into 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 11, 2026, and is solely responsible for the information co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLb37MLr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232329","title":"AN2 Therapeutics Q1 EPS USD -0.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232329?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nPLX8BB9EA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232680","title":"Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232680?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":"Oral epetraborole program in polycythemia vera advancing toward Phase 2. Phase 2 investigator-initiated trial with epetraborole for M. abscessus lung disease underway. Data expected in 2Q/2026 from two studies of oral AN2-502998, under development for chronic Chagas disease: a Phase 1 first-in-human clinical trial and a non-human primate efficacy study. Declared ENPP1 candidate for solid tumors advancing from early research into development. AN2 Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the first quarter ended March 31, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMC","IE00BHPRN162.USD","LU2237443895.HKD","LU1363072403.SGD","BK4007","BK4225","LU2237443382.USD","LU0882574139.USD","LU0170899867.USD","LU2746668461.USD","BK4139","IE00BFXG1179.USD","BK4006","LU2746668974.SGD","NHP","LU2237443622.USD","LU2237443465.HKD","IE00B1BXHZ80.USD","LU0971096721.USD","IE00BKVL7J92.USD","LENZ","LU0149725797.USD","LU2237443978.SGD","LU0267386448.USD","IE00BZ1G4Q59.USD","BK4539","ANTX","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633176854","title":"AN2 Therapeutics CEO joins Stifel Virtual Targeted Oncology Forum fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2633176854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633176854?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:02","pubTimestamp":1778184169,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics scheduled to join 2026 Stifel Virtual Targeted Oncology Forum on May 19, 2026.Management also set to hold 1x1 meetings during forum.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL9ckcdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007","SF","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631652328","title":"AN2 Therapeutics Inc  expected to post a loss of 23 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2631652328","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631652328?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:02","pubTimestamp":1777492932,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc  expected to post a loss of23cents a share - Earnings Preview AN2 Therapeutics Inc ANTX.OQ ANTX.O is expected to  show no change in quarterly revenue when it reports  results on M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nL8N41C394:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027274","title":"AN2 Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027274?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:07","pubTimestamp":1776888442,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics scheduled 2026 annual stockholders meeting for June 3 in Menlo Park, California.Shareholders will vote on election of three Class I director nominees: Kabeer Aziz, Gilbert Lynn Marks, Rob Readnour.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL1ZL1XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629177610","title":"BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2629177610","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629177610?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:35","pubTimestamp":1776717349,"startTime":"0","endTime":"0","summary":"BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies April 20  - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS INC - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC DATED APRIL 9, 2026 - SEC FILINGAN2 THERAPEUTICS INC - MAY OFFER AND SELL COMMON STOCK UP TO $80 MILLION THROUGH JEFFERIES - SEC FILINGSource text: [ID:n0001193125-26-164095]Further company coverage: ANTX.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629776125","title":"AN2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies Llc Dated April 9, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629776125","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629776125?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:34","pubTimestamp":1776717242,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629377612","title":"AN2 Therapeutics Inc - May Offer and Sell Common Stock up to $80 Mln Through Jefferies - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629377612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629377612?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:34","pubTimestamp":1776717242,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130WO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626558101","title":"BRIEF-An2 Therapeutics Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626558101","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626558101?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:03","pubTimestamp":1775772197,"startTime":"0","endTime":"0","summary":"BRIEF-An2 Therapeutics Inc - May Offer And Sell Up To $300 Million Of Securities - SEC FilingApril 9  - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS INC - MAY OFFER AND SELL UP TO $300 MILLION OF SECURITIES - SEC FILINGAN2 THERAPEUTICS INC - SELLING SECURITYHOLDERS MAY OFFER UP TO 14.04 MILLION SHARES OF COMMON STOCK - SEC FILINGAN2 THERAPEUTICS INC - MAY OFFER UP TO $80 MILLION OF COMMON STOCK UNDER AGREEMENT WITH JEFFERIES LLC - SEC FILINGSource text: [ID:n0001193125-26-149869]Further company coverage: ANTX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626153713","title":"AN2 Therapeutics Files $300 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2626153713","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626153713?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:50","pubTimestamp":1775771416,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics  filed a shelf registration statement with US regulators on late Thursday for the potential sale of up to $300 million in securities, to be offered from time to time.The filing covers common stock, preferred stock, debt securities, warrants and units.The company said it will not receive any proceeds from the sale of common stock by selling securityholders.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANTX","BK4539","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626153108","title":"AN2 Therapeutics files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2626153108","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626153108?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:25","pubTimestamp":1775769944,"startTime":"0","endTime":"0","summary":"17:22 EDT AN2 Therapeutics (ANTX) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-files-300m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626153665","title":"AN2 Therapeutics Inc - May Offer up to $80 Mln of Common Stock Under Agreement With Jefferies Llc - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626153665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626153665?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:21","pubTimestamp":1775769713,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S18X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626580381","title":"AN2 Therapeutics Inc - Enters Open Market Sale Agreement With Jefferies for up to $80 Mln Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626580381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626580381?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:05","pubTimestamp":1775768743,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S1E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626158087","title":"AN2 Therapeutics Inc - Terminates TD Cowen Sales Agreement Effective April 9, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626158087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626158087?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:05","pubTimestamp":1775768743,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S1E8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626158719","title":"AN2 Therapeutics enters $80 million at-the-market equity sales agreement with Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2626158719","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626158719?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:04","pubTimestamp":1775768663,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics entered an at-the-market equity distribution agreement with Jefferies for up to USD 80 million of common stock.Jefferies will act as sales agent, earning commission up to 3% of gross proceeds.Agreement allows sales from time to time on Nasdaq Global Select Market, subject to company instructions.AN2 terminated prior ATM sales agreement with TD Securities, under which it sold 2,502,000 shares for USD 20,016,251.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL47RJYy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555810","title":"AN2 Therapeutics starts Phase 2 epetraborole trial in M. abscessus lung disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555810","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555810?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:57","pubTimestamp":1774990644,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics initiated Phase 2 investigator-led trial of oral epetraborole for Mycobacterium abscessus complex lung disease.Study will evaluate safety, efficacy, pharmacokinetics in 84 patients in randomized, double-blind, multicenter design.Patient screening started across an estimated 10-15 U.S. sites.Topline results will be presented in late 2027.Program targets condition with no FDA-approved therapies, positioning epetraborole as potential backbone agent for future multidrug regimens if data are positive.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on March 31, 2026, and is solely responsible for the information contained","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL49PwZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623658332","title":"AN2 Therapeutics Inc - Expects Three Phase 2 Studies Active in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623658332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623658332?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:00","pubTimestamp":1774954801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA74NNVS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623583376","title":"AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium Abscessus Complex Lung Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2623583376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623583376?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:00","pubTimestamp":1774954801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA74NNVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":54,"code":"91000000","status":"200"}]}}